28.4 C
Vientiane
Tuesday, September 23, 2025
spot_img
Home Blog Page 75

Arkieva announces Anand Iyer as CEO

Supply chain planning veteran brings technical expertise, experience scaling go-to-market functions to lead company through next phase of growth

WILMINGTON, Del., Sept. 15, 2025 /PRNewswire/ — Arkieva, a provider of industry-leading supply chain planning solutions, announces Anand Iyer as its new CEO. Iyer brings 30 years of experience to Arkieva, with a proven track record of leading organizations through transformational periods. His supply chain and technology background includes leadership roles at i2 Technologies, now Blue Yonder, and Serus Corporation, now e2Open.

“Arkieva has a strong foundation, and I’m confident that Anand is the right leader to take the company forward,” says Harpal Singh, Founder, Arkieva. “Throughout his career, he’s earned praise as an inspiring leader, with a record of helping clients with innovative strategies. As global supply chains continue to evolve, his expertise and vision are the right fit to drive this next phase of growth for Arkieva.”

Iyer joins Arkieva at a pivotal stage of the company’s history, following Banneker Partners’ strategic investment in the company earlier this year. The partnership aims to equip Arkieva for a new phase of growth, enabling the company to sustain its leading position and address evolving market demand.

“Arkieva has built a strong reputation for delivering measurable results for clients facing complex supply chain challenges,” says Iyer. “In this next phase, I look forward to expanding on that track record as our customers strive to build agile and resilient supply chains amid shifting trade rules and increasing global pressures.”

Arkieva was recently positioned as a Challenger in the 2025 Gartner Magic Quadrant for Supply Chain Planning Solutions. The company’s modern SaaS suite, which offers unrivaled digital twin and autonomous control tower capabilities, is trusted by global manufacturers and distributors to manage over $110 billion in revenue planning.

“As Anand worked with the leadership team to develop the best path ahead for Arkieva, it became clear that he is not only a trusted advisor, but the right person to guide Arkieva into its next phase of growth as CEO,” says Chirag Shah, Operating Partner at Banneker Partners. “Anand’s deep expertise in supply chain strategy, planning and execution, combined with his experience driving operational excellence, make him the right leader to strengthen Arkieva’s position as a trusted partner.”

Iyer holds a doctorate in Systems and Industrial Engineering from the University of Arizona. Outside of the supply chain industry, he has served in upper management positions at Quantum Spatial, a geospatial analytics firm, and Riverside Insights, a specialist in research-backed educational and clinical assessments.

To access images, click here.

About Arkieva
For more than 30 years, Arkieva has helped global enterprises drive business transformation through improved supply chain processes. The company’s demand, inventory, supply and integrated business planning solutions increase growth and profits, and provide the agility and efficiency needed to respond to an ever-changing supply chain environment. Our approach combines strategic consultation, powerful software technologies and iterative implementation to deliver scalable solutions tailored to the complexities of each customer’s operations. Arkieva’s culture of innovation keeps customers like Linde, Messer and INEOS at the forefront of supply chain planning.

Arkieva is headquartered in Wilmington, Delaware USA with offices in Antwerp, Belgium and Mangalore, India. For more information, visit www.arkieva.com.

CONNECT WITH ARKIEVA

Arkieva Media Contact:
Kristan Theile
Director of Marketing, Arkieva
513-376-0300
ktheile@arkieva.com

 

EmeTerm Wearable Device Under Clinical Study at Ohio State Wexner Medical Center Shows Promise for Chronic Nausea Patients

VANCOUVER, BC, Sept. 15, 2025 /PRNewswire/ — WAT Medical Enterprise Ltd. is proud to announce that its innovative anti-nausea wristband, EmeTerm, has made significant progress in alleviating nausea and vomiting among patients suffering from chronic gastric disorders. A clinical study currently underway at The Ohio State University Wexner Medical Center is evaluating the device’s impact on individuals with moderate to severe chronic nausea, a condition that affects millions worldwide.

A Growing Unmet Medical Need
Chronic nausea and vomiting remain challenging to treat. According to the American College of Gastroenterology (ACG), up to 12% of the U.S. population may suffer from functional dyspepsia and related chronic gastric disorders, with nausea being one of the most debilitating symptoms (ACG Clinical Guideline, 2022). Standard antiemetic medications often carry side effects such as fatigue, dizziness, and constipation, limiting long-term use.

Globally, the antiemetic drug market was valued at USD 4.8 billion in 2022 and is projected to grow at a CAGR of 6.2% through 2030 (Grand View Research, 2023). The demand for safe, non-invasive, drug-free alternatives is steadily rising.


How EmeTerm Works
EmeTerm employs transcutaneous electrical acustimulation (TEAS) technology. The device delivers gentle electrical pulses to the median nerve on the wrist, modulating neural signals between the gut and the brain. This mechanism helps reduce nausea and prevent vomiting—without the side effects typically associated with pharmacological treatments.

Clinical evidence supports EmeTerm efficacy of reduce nausea and prevent vomiting. A multicenter randomized controlled trial demonstrated that EmeTerm significantly reduced the incidence of postoperative nausea and vomiting (PONV) in patients undergoing hysteroscopic surgery (Wang, 2022).

Unlike medications that must be taken regularly, EmeTerm can be worn on-demand, making it a practical tool for individuals managing unpredictable or chronic episodes of nausea. EmeTerm is already FDA-cleared as an over-the-counter device for nausea relief, including motion sickness and pregnancy-related nausea.

Promising Strides at Ohio State University

Ohio State University hopes to conduct research on using modern medical technologies to control chronic gastrointestinal diseases. Since 2023, The Ohio State University Wexner Medical Center has been conducting a clinical study to evaluate the potential of EmeTerm as a supportive therapy for chronic gastrointestinal disorders. 

This trial marks a critical step in evaluating its potential as a therapeutic adjunct for chronic gastrointestinal conditions. Final study results are anticipated in the coming months. Recent results show that nearly 50% of patients with moderate to severe nausea experienced meaningful relief, while approximately 30% of participants suffering from vomiting also reported improvement.

The study, launched in 2023 and expected to conclude in 2026, is closely monitoring patients with conditions such as gastroparesis, chronic gastritis, and other gastrointestinal disorders. Researchers are tracking the device’s effectiveness across a wide spectrum of gastric diseases to confirm its benefits for a broad patient population.

References
1. American College of Gastroenterology. (2022). ACG clinical guideline: Gastroparesis, functional dyspepsia, and chronic nausea and vomiting disorders. The American Journal of Gastroenterology, 117(7), 1197–1220. https://doi.org/10.14309/ajg.0000000000001835

2. Grand View Research. (2023). Antiemetic drugs market size, share & trends analysis report by drug type, by distribution channel, by region, and segment forecasts, 2023–2030. Retrieved from https://www.grandviewresearch.com/industry-analysis/antiemetic-drugs-market

3. Wang, N., et al. (2022). Wearable transcutaneous electrical acupoint stimulation bracelet for prevention of postoperative nausea and vomiting in patients undergoing hysteroscopic surgery: a randomised controlled trial. British Journal of Anaesthesia, 129(4), e85-e87.

4. www.watmedical.com 

5. www.emeterm.com 

The Pinkfong Company Partners with Mattel to Distribute Legacy Pingu Content to New Audiences in Korea

–  A powerhouse partnership in family entertainment to reintroduce a timeless stop-motion classic to new audiences in Korea

Download image here

SEOUL, South Korea, Sept. 15, 2025 /PRNewswire/ — The Pinkfong Company, the global entertainment company behind Baby Shark, announced an exclusive distribution partnership with Mattel, Inc. (NASDAQ: MAT), a leading global toy and family entertainment company and owner of one of the most iconic brand portfolios in the world, to reintroduce the beloved stop-motion classic Pingu to audiences in Korea. The Pinkfong Company will exclusively distribute Pingu episodes from the 90s and 2000s in the domestic market, including the Pingu Classic Series, the Pingu at the Wedding Party special, and Pingu in the City. The episodes will premiere on September 19, with new episodes released weekly on leading pay-TV and digital platforms.

The Pinkfong Company Partners with Mattel to Distribute Legacy Pingu Content to New Audiences in Korea
The Pinkfong Company Partners with Mattel to Distribute Legacy Pingu Content to New Audiences in Korea

With original family IPs such as Baby Shark and Bebefinn, The Pinkfong Company has built a diverse portfolio that resonates with audiences of all ages. Mattel, renowned for iconic global brands including Barbie and Hot Wheels, continues to expand its storytelling across content and media. Through this partnership, the two companies are creating meaningful synergies — combining Mattel’s IP with The Pinkfong Company’s growing role as a trusted local partner in distributing internationally renowned properties.

Since its debut in the 1980s, Pingu has won the hearts of audiences in more than 150 countries with its whimsical stop-motion charm and universal humor. Featuring the mischievous young penguin and his signature “Noot Noot!,” the series blends family themes with timeless comedy, cementing its status as a beloved pop culture icon across generations.

Pingu is one of the most iconic stop-motion properties of all time, and we are thrilled to bring this timeless classic back to Korean audiences through our partnership with Mattel,” said Gemma Joo, Chief Business Officer at The Pinkfong Company. “This marks an exciting new chapter in sharing Pingu‘s universal charm and playful spirit, reinforcing our dedication to family entertainment that transcends generations.”

“Mattel is excited to partner with The Pinkfong Company to reintroduce Pingu’s adventures to a new generation of fans in Korea,” said Alex Godfrey, Vice President, Global Content Distribution at Mattel. “We are committed to sharing our iconic brands with audiences worldwide and look forward to building upon Pingu’s impact and enduring global appeal.”

This partnership reflects The Pinkfong Company’s ongoing commitment to delivering high-quality family entertainment through its original IPs and key collaborations with leading global brands like Mattel. It also underscores the company’s mission to bring joyful content that connects audiences across generations and regions.

About The Pinkfong Company

The Pinkfong Company is a global entertainment company that delivers content and entertaining experiences around the world. Driven by award-winning brands and IPs, the company has created and distributed a range of content across genres and formats including original animated series, world live tours, interactive games, and more. Believing in the power of entertaining and engaging content, The Pinkfong Company is committed to connecting people around the world and bringing joy and inspiration to worldwide audiences of all ages. For more information, please visit the website or follow the company on LinkedIn.

About Mattel

Mattel is a leading global toy and family entertainment company and owner of one of the most iconic brand portfolios in the world. We engage consumers and fans through our franchise brands, including Barbie®, Hot Wheels®, Fisher-Price®, American Girl®, Thomas & Friends™, UNO®, Masters of the Universe®, Matchbox®, Monster High®, Polly Pocket®, and Barney®, as well as other popular properties that we own or license in partnership with global entertainment companies. Our offerings include toys, content, consumer products, digital and live experiences. Our products are sold in collaboration with the world’s leading retail and ecommerce companies. Since its founding in 1945, Mattel is proud to be a trusted partner in empowering generations to explore the wonder of childhood and reach their full potential. Visit us at mattel.com

Media Contact
Hailey Kim
Communications Manager
The Pinkfong Company
hailey@pinkfong.com

Kensie Sanchez Krompier
Mattel
Kensie.Krompier@mattel.com

BioCatch Receives Frost & Sullivan’s 2025 Global Competitive Strategy Leadership Recognition for Excellence in Fraud Detection and Prevention

This recognition underscores BioCatch’s strategic focus on fraud detection and prevention for the BFSI industry leveraging behavioral biometrics and customer collaboration

SAN ANTONIO, Sept. 15, 2025 /PRNewswire/ — Frost & Sullivan is pleased to announce that BioCatch, which prevents financial crime by recognizing patterns in human behavior, has earned the 2025 Global Competitive Strategy Leadership Recognition in the BFSI fraud detection and prevention (FDP) industry for its outstanding achievements in strategy execution, innovation, and customer impact. This recognition highlights BioCatch’s consistent leadership in combating fraud, strengthening its market position, and delivering customer-centric innovation in an evolving threat landscape.

Frost & Sullivan’s evaluation focused on key areas of strategic effectiveness and execution. BioCatch demonstrates excellence by aligning its strategic initiatives with market demands, and by executing these strategies efficiently, consistently, and at scale—resulting in a distinct competitive advantage. “BioCatch’s behavioral biometric assets, targeted market approach, and customer collaboration are strategic advantages. Its deployment at more than 30 of the top 100 global banks shows the success of its strategy,” said Deepali Sathe, Senior Industry Analyst at Frost & Sullivan.

BioCatch’s long-term strategy is centered on fraud detection and prevention in the financial services sector. The company’s continuous investment in research and development, supported by customer feedback, has helped it address new security challenges and expand its presence in global markets.

Innovation is fundamental to BioCatch’s strategy, which is evident in the more than 90 patents it owns. The company’s fraud detection and prevention platform utilizes behavioral intelligence to effectively mitigate advanced forms of fraud such as social engineering scams, account takeover (ATO), mule accounts, and automated bot attacks.

“This recognition is a testament to our customers, who inspire us to continually push the boundaries of fraud prevention,” BioCatch Chief Strategy Officer Amelia Ahlgren said. “We are laser-focused on the financial services industry, where we deeply understand our customers’ challenges and partner with them to deliver innovation that makes banking safer every day. By aligning our strategy with their needs, we ensure our solutions drive measurable impact and lasting consumer trust.”

BioCatch demonstrates a strong dedication to customer success, which reinforces its leadership in the market. The company facilitates efficient implementation through a modular platform, offers flexible deployment solutions, and upholds exceptional service availability. Through direct engagement with leading global banks and a partner-led delivery model for the mid-market sector and direct engagement with leading global banks, BioCatch ensures scalable and effective value delivery across a broad range of market segments.

Frost & Sullivan commends BioCatch for setting a high standard in competitive strategy, execution, and market responsiveness. The company’s vision, innovation pipeline, and customer-first culture are shaping the future of fraud detection and prevention in the BFSI industry and driving tangible results at scale.

Each year, Frost & Sullivan presents the Competitive Strategy Leadership Recognition to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. The recognition highlights forward-thinking organizations that are reshaping their industries through innovation and growth excellence.

Frost & Sullivan Best Practices Recognition
Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.

Contact us: Start the discussion.

Contact:
Ashley Shreve
E: ashley.weinkauf@frost.com 

About BioCatch
BioCatch prevents financial crime by recognizing patterns in human behavior, continuously collecting more than 3,000 anonymized data points – keystroke and mouse activity, touch screen behavior, physical device attributes, and more – as people interact with their digital banking platforms. With these inputs, BioCatch’s machine-learning models reveal patterns in user behavior and provide device intelligence that, together, distinguish the criminal from the legitimate. The company’s Customer Innovation Board – an industry-led initiative in partnership with American Express, Barclays, Citi Ventures, HSBC, National Australia Bank, and others – collaborates to pioneer innovative ways of leveraging customer relationships for improved fraud detection. Today, more than 30 of the world’s largest 100 banks and 287 total financial institutions deploy BioCatch solutions, analyzing 16 billion user sessions per month and protecting more than 532 million people on more than 1.6 billion devices around the world from fraud and financial crime.

Media/PR contact:
Mac King E: Mac.King@BioCatch.com

 

MAS9 Brings Digital Transformation to U.S. Martial Arts Schools With AI-Powered SaaS Platform

SEOUL, South Korea , Sept. 15, 2025 /PRNewswire/ — South Korean startup MAS9 has made a rapid entry into the U.S. Taekwondo market, onboarding more than 100 schools within a month of launching its paid SaaS platform. The company’s solution is the first business-to-business-to-consumer (B2B2C) digital management system designed specifically for martial arts schools in the United States.

The platform replaces manual administrative tasks—such as tuition collection, overdue payment reminders, and attendance tracking—with a fully automated system. Parents and students also benefit from real-time access to class schedules, training progress, and instructor feedback via MAS9’s dedicated mobile app and website.

Building on this momentum, MAS9 will introduce a one-click e-commerce feature in January 2026, giving school owners a new revenue opportunity. Without carrying inventory, owners will be able to launch online shops and sell uniforms, equipment, and merchandise directly to students and parents through the platform. The U.S. Taekwondo merchandise market is estimated at around $400 million, and MAS9’s upcoming feature is designed to help school operators capture this demand more effectively..

“MAS9 provides both operational efficiency and financial upside for school owners, which explains the strong adoption we’ve seen in such a short time,” said Dongho Ryoo, CEO of MAS9 USA. He added that the company has been able to accelerate adoption by rapidly incorporating feedback from U.S. school operators, leveraging more than two decades of local market experience.

Looking forward, MAS9 plans to integrate artificial intelligence into its system, with features such as student retention analytics, personalized training content, and financial forecasting tools.

Sang-Youb Lee, CEO of MAS9 said the company’s long-term ambition is to build a global Taekwondo business platform. “With 700,000 schools, 1.5 million instructors, and 80 million practitioners worldwide, Taekwondo represents a massive opportunity. Our early success in the U.S. validates our strategy and lays the groundwork for international expansion.”

FEELINGIRL Honored at MUSE Design Awards for Redefining Post-Surgery Shapewear

RANCHO CUCAMONGA, Calif., Sept. 15, 2025 /PRNewswire/ — FEELINGIRL, a brand renowned for its technology-driven shapewear, once again took center stage with the FEELINGIRL Bra collection. Dedicated to enhancing women’s confidence, FEELINGIRL is committed to creating comfortable, close-fitting lingerie designed for women of all ages and life stages. With its latest FeelCare collection, the brand has been honored with the Silver Award in the Fashion Design category at the prestigious MUSE Design Awards.

FEELINGIRL Honored at MUSE Design Awards for Redefining Post-Surgery Shapewear
FEELINGIRL Honored at MUSE Design Awards for Redefining Post-Surgery Shapewear

The MUSE Design Awards, one of the most prestigious honors in the global design community, celebrates innovation and excellence across multiple disciplines. This year’s competition attracted nearly 10,000 entries from around the world, with evaluation criteria spanning creativity, functionality, social value, and breakthroughs in aesthetics.

The award-winning FeelCare collection represents the culmination of the brand’s long-standing commitment to fabric technology innovation for the FEELINGIRL Bra collection. Trusted by consumers, the FEELINGIRL Bra collection has earned recognition for comfort, functional materials, and technology-driven shaping. The brand invests in textile research and development, advancing support, breathability, and skin-friendliness. With years of expertise in everyday lingerie, FEELINGIRL has transferred these innovations to the demanding field of post-surgery recovery, creating a milestone collection that combines medical functionality with human-centered design.

The FEELINGIRL FeelCare post-surgery shapewear collection is a product line designed with women’s recovery needs as its primary focus. Developed with ergonomic structure, intelligent support systems, and advanced functional fabrics, the collection provides tailored solutions for the unique challenges women face during post-surgical recovery. Two core products anchor the collection: a post-surgery bra and shaping pants. Together, they target the chest and waist-abdominal regions to deliver reliable support and contouring, balancing practicality with comfort across various daily scenarios, from early recovery to commuting or at-home wear.

The post-surgery bra stands out for its thoughtful details and focus on both comfort and support. Its full-coverage, wire-free construction avoids padded cups while offering a stable structure, minimizing pressure and movement during sensitive recovery stages. Bust-enhancing panels subtly lift and shape, while the hem features the brand’s exclusive logo elastic band that prevents sagging and ensures secure contouring. Inside, a molding process creates space for a seamless, natural bust profile. Wide, adjustable shoulder straps reduce shoulder strain while enhancing back contours. For convenience, especially important during recovery, the bra incorporates a front-center three-row hook design, allowing easier dressing and a better fit for different body types.

Complementing the bra, the shaping pants emphasize waist and abdominal support with a high-waist, double-layer compression structure. This design stabilizes the waistline, flattens the stomach, and defines contours, while built-in lifting panels naturally enhance the hips to create a seamless, sculpted silhouette. Boning in the back waist prevents rolling and supports lumbar stability, while a front zipper-and-hook system ensures secure wear. A separate crotch zipper enhances practicality, recognizing the everyday needs of women in recovery.

Beyond individual product features, the FeelCare collection distinguishes itself through structural optimization rooted in multidimensional human body curve data. By applying zoned compression technology, the garments provide precise shaping and support for the waist, abdomen, and hips. A 360-degree four-way stretch wrap enhances comfort, while the front waist-abdomen incorporates a shaping mesh layer to create a three-layer contouring system. These innovations together form a collection that merges science-driven precision with user-focused comfort.

In a competitive global field, the FeelCare collection stood out for its ability to address women’s post-surgery recovery needs with products that respect both function and dignity. With the FeelCare collection, FEELINGIRL has demonstrated that shapewear can serve as more than a functional garment; it can become a meaningful part of recovery and confidence-building. The award signals a significant step for the brand on the global stage, reaffirming its commitment to advancing women’s health through thoughtful design and innovation.

For more details, please visit: https://feelingirl.com/ or search “FEELINGIRL” on Amazon.   

Locksley Resources Announces Significant Expansion of its Exploration Program for both Rare Earths and Antimony After Increasing its Landholding to More than 40 Square Kilometers in California’s Mojave Region

SAN BERNARDINO, Calif., Sept. 15, 2025 /PRNewswire/ — Locksley Resources Ltd. (ASX: LKY; OTCQB: LKYRF) announced it will significantly expand its exploration program at its significantly increased landholding in the Mojave Desert. Earlier this month the company announced the addition of 249 additional claims at the site, which abuts areas currently controlled by MP Materials, the only Rare Earths producing mine in North America. These new claims bring the company’s total landholding to 491 claims encompassing more than 40 sq km of highly prospective critical minerals. Additional details can be found here: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02993242-6A1283793&v=c2533a54e2514fb77a8f93f84db686e1125273e9

“The substantial expansion of our landholding within the Mojave Critical Minerals Corner marks a pivotal step in Locksley’s growth,” said Pat Burke, Chairman of Locksley Resources. He reported that last week brokers and analysts visited the site, affording Locksley an excellent opportunity to highlight both the scale of the tenure, as well as the strategic importance of its position in this area.

“With the U.S. Government increasingly focused on securing domestic supply chains for critical minerals, Locksley is well positioned to deliver a mine-to-market solution for antimony and rare earths,” Burke said.

The expanded program will be focused on exploration of both the existing antimony and rare earths elements prospects as well as targeting additional commodities that have been identified on Locksley’s larger land holding. A substantial historical shaft has been discovered during a surface geological and structural mapping campaign recently undertaken by Locksley at Mojave. The shaft depth and the extent of the underground workings are being further evaluated and is estimated at more than 15m. Locksley is determining the composition of the commodities that were historically mined.

Locksley Resources (https://www.locksleyresources.com.au) is an Australian-based explorer focused on critical minerals and base metals, with assets in both the U.S. and Australia. The company is actively advancing its U.S. asset, the Mojave Project, in California, targeting rare earth elements (REEs) and antimony. The company has also announced a strategic collaboration with Rice University to develop DeepSolv™, for domestic processing of North American antimony. The agreement is the first step in the initiation of Locksley’s U.S. Critical Minerals and Energy Resilience Strategy to accelerate “mine-to-market” deployment of antimony in the U.S.

Contact: Beverly Jedynak, Beverly.jedynak@viriathus.com, 312-943-1123; 773-350-5793 (cell)

Korea reinforces biopharma leadership at Global Bio Conference 2025

SEOUL, South Korea, Sept. 15, 2025 /PRNewswire/ — This is an article published in The Korea Herald:

The Ministry of Food and Drug Safety on Thursday announced its successful hosting of the Global Bio Conference 2025 in Seoul last week, under the theme “Bio, Navigating Infinite Possibilities.”

The three-day event — held Sept. 3-5 at the Grand InterContinental Seoul Parnas in southern Seoul — brought together about 4,530 participants, including 94 experts from 21 countries, alongside representatives from academia, the pharmaceutical industry and regulatory authorities.

The conference, marking its eleventh year, provided a platform to share the latest research, development and regulatory trends, and discuss strategies for future growth.

It highlighted the latest developments in advanced biopharmaceuticals, covering quality management trends and global regulatory harmonization, and reviewed cases of emerging vaccine platforms such as self-amplifying RNA.

Emerging challenges amid rapid technological advances, such as artificial intelligence and regulatory considerations to expand patient access, were also addressed.

Global regulatory cooperation was another focal point. Officials from Europe, Australia, Ecuador, Japan, Thailand and other countries joined the global regulators workshop to share practices on approval and review systems, policy updates and collaborative initiatives.

The head of Ecuador’s regulatory authority attended to request effective implementation of the reference system to accelerate the approval of Korean medicines, while a dedicated session with pharmaceutical firms explored strategies for entering Latin American markets.

The Food and Drug Safety Ministry commented that it will continue to support the conference as a leading platform for global regulatory cooperation, while promoting the competitiveness of Korean biopharmaceuticals and supporting them in achieving early entry into overseas markets.

A total of 11 one-on-one meetings between Korean companies and overseas regulators were held during the conference, aiming to support their global market expansion and address industry challenges.